Home › NDC Lookup › RxCUI directory › RxCUI 2705568

0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe — RxCUI 2705568

RxNorm drug concept · Semantic clinical drug
RxCUI 2705568 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2705568
Official name0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asustekinumab-ttwe 45 MG per 0.5 ML Prefilled Syringe; ustekinumab-ttwe 45 MG in 0.5 ML Prefilled Syringe
FDA products mapped9
Package NDCs mapped12
Reported Medicaid activity (SDUD)357 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ustekinumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ustekinumab is approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active u...
  • What conditions does ustekinumab treat, and is it right for me?
  • It depends on your condition. For Crohn's disease and ulcerative colitis, the first dose is given as an IV infusion in a clinical setting. After that, you switch to under-the-skin...
  • How is ustekinumab given, and will I need to go to a clinic every time?
📖 Read our full Ustekinumab Injection guide →

🕸️ Concept Web — How 0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe RxCUI 2705568

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ustekinumab 847083
    • Ustekinumab-ttwe 2705553
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pyzchiva 2705559
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ustekinumab Prefilled Syringe 853349
    • Ustekinumab-ttwe Prefilled Syringe 2705567
    • Ustekinumab Injectable Product 1163983
    • Ustekinumab-ttwe Injectable Product 2705555
    • Ustekinumab Prefilled Syringe [Pyzchiva] 2705571
    • Ustekinumab-ttwe Prefilled Syringe [Pyzchiva] 2705572
    • Pyzchiva Injectable Product 2705561
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ustekinumab-ttwe 90 MG/ML SCDC · 2705566
  • Ustekinumab Prefilled Syringe SCDF · 853349
  • Ustekinumab-ttwe Prefilled Syringe SCDFP · 2705567
  • Ustekinumab Injectable Product SCDG · 1163983
  • Ustekinumab-ttwe Injectable Product SCDGP · 2705555

Brand-Name Concepts

  • 0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe [Pyzchiva] SBD · 2705573
  • Ustekinumab-ttwe 90 MG/ML [Pyzchiva] SBDC · 2705570
  • Ustekinumab Prefilled Syringe [Pyzchiva] SBDF · 2705571
  • Ustekinumab-ttwe Prefilled Syringe [Pyzchiva] SBDFP · 2705572
  • Pyzchiva Injectable Product SBDG · 2705561
  • Pyzchiva BN · 2705559

📦 FDA Products & Package NDCs

9 products · 12 package NDCs
12 package NDCs map to RxCUI 2705568 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61314-0651-01 1 SYRINGE in 1 CARTON (61314-651-01) / .5 mL in 1 SYRINGE PYZCHIVA SANDOZ INC 2025-02-22
61314-0651-94 1 VIAL in 1 CARTON (61314-651-94) / .5 mL in 1 VIAL PYZCHIVA SANDOZ INC 2025-06-23
61314-0652-01 1 SYRINGE in 1 CARTON (61314-652-01) / 1 mL in 1 SYRINGE PYZCHIVA SANDOZ INC 2025-02-22
61314-0654-94 1 VIAL, SINGLE-USE in 1 CARTON (61314-654-94) / 26 mL in 1... PYZCHIVA SANDOZ INC 2025-02-22
82009-0160-11 1 SYRINGE in 1 CARTON (82009-160-11) / .5 mL in 1 SYRINGE USTEKINUMAB-TTWE Quallent Pharmaceuticals Health LLC 2025-04-15
82009-0161-94 .5 mL in 1 VIAL (82009-161-94) USTEKINUMAB-TTWE Quallent Pharmaceuticals Health LLC 2026-02-15
82009-0162-11 1 SYRINGE in 1 CARTON (82009-162-11) / 1 mL in 1 SYRINGE USTEKINUMAB-TTWE Quallent Pharmaceuticals Health LLC 2025-04-15
82009-0163-94 1 VIAL, SINGLE-USE in 1 CARTON (82009-163-94) / 26 mL in 1... USTEKINUMAB-TTWE Quallent Pharmaceuticals Health LLC 2025-04-15
83457-0651-01 1 SYRINGE in 1 CARTON (83457-651-01) / .5 mL in 1 SYRINGE PYZCHIVA Cordavis Limited 2025-05-01
83457-0651-96 1 SYRINGE in 1 CARTON (83457-651-96) / .5 mL in 1 SYRINGE PYZCHIVA Cordavis Limited 2025-08-14
83457-0652-01 1 SYRINGE in 1 CARTON (83457-652-01) / 1 mL in 1 SYRINGE PYZCHIVA Cordavis Limited 2025-05-01
83457-0652-96 1 SYRINGE in 1 CARTON (83457-652-96) / 1 mL in 1 SYRINGE PYZCHIVA Cordavis Limited 2025-08-14
Observed labelers: Cordavis Limited (4) · Quallent Pharmaceuticals Health LLC (4) · SANDOZ INC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q9997 Ustekinumab-ttwe iv inj 1 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.